139 related articles for article (PubMed ID: 12213988)
1. C-reactive protein and coronary heart disease: diagnostic and therapeutic implications for primary prevention.
Rifai N
Cardiovasc Toxicol; 2001; 1(2):153-7. PubMed ID: 12213988
[TBL] [Abstract][Full Text] [Related]
2. High-sensitivity C-reactive protein: a novel and promising marker of coronary heart disease.
Rifai N; Ridker PM
Clin Chem; 2001 Mar; 47(3):403-11. PubMed ID: 11238289
[TBL] [Abstract][Full Text] [Related]
3. High-sensitivity C-reactive protein and atherosclerosis: from theory to therapy.
Yu H; Rifai N
Clin Biochem; 2000 Nov; 33(8):601-10. PubMed ID: 11166006
[TBL] [Abstract][Full Text] [Related]
4. Comparative analysis of red cell distribution width and high sensitivity C-reactive protein for coronary heart disease mortality prediction in multi-ethnic population: findings from the 1999-2004 NHANES.
Veeranna V; Zalawadiya SK; Panaich S; Patel KV; Afonso L
Int J Cardiol; 2013 Oct; 168(6):5156-61. PubMed ID: 24016543
[TBL] [Abstract][Full Text] [Related]
5. High-sensitivity C-reactive protein and atherosclerotic disease: from improved risk prediction to risk-guided therapy.
Koenig W
Int J Cardiol; 2013 Oct; 168(6):5126-34. PubMed ID: 23978367
[TBL] [Abstract][Full Text] [Related]
6. The relative strength of C-reactive protein and lipid levels as determinants of ischemic stroke compared with coronary heart disease in women.
Everett BM; Kurth T; Buring JE; Ridker PM
J Am Coll Cardiol; 2006 Dec; 48(11):2235-42. PubMed ID: 17161253
[TBL] [Abstract][Full Text] [Related]
7. [C-reactive protein in patients with coronary heart disease].
Rajtar R; Kolasińska-Kloch W; Kloch M
Folia Med Cracov; 2004; 45(1-2):25-32. PubMed ID: 16276823
[TBL] [Abstract][Full Text] [Related]
8. High sensitivity C-reactive protein: an emerging role in cardiovascular risk assessment.
Benzaquen LR; Yu H; Rifai N
Crit Rev Clin Lab Sci; 2002 Sep; 39(4-5):459-97. PubMed ID: 12385503
[TBL] [Abstract][Full Text] [Related]
9. Association of high sensitivity C-reactive protein with coronary heart disease prediction, but not with carotid atherosclerosis, in patients with hypertension.
Choi H; Cho DH; Shin HH; Park JB
Circ J; 2004 Apr; 68(4):297-303. PubMed ID: 15056824
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease.
Sabatine MS; Morrow DA; Jablonski KA; Rice MM; Warnica JW; Domanski MJ; Hsia J; Gersh BJ; Rifai N; Ridker PM; Pfeffer MA; Braunwald E;
Circulation; 2007 Mar; 115(12):1528-36. PubMed ID: 17372173
[TBL] [Abstract][Full Text] [Related]
11. C-reactive protein: a new risk assessment tool for cardiovascular disease.
Clearfield MB
J Am Osteopath Assoc; 2005 Sep; 105(9):409-16. PubMed ID: 16239491
[TBL] [Abstract][Full Text] [Related]
12. C-reactive protein, inflammation, and coronary risk.
Ridker PM; Morrow DA
Cardiol Clin; 2003 Aug; 21(3):315-25. PubMed ID: 14621448
[TBL] [Abstract][Full Text] [Related]
13. Prognostic utility of apoB/AI, total cholesterol/HDL, non-HDL cholesterol, or hs-CRP as predictors of clinical risk in patients receiving statin therapy after acute coronary syndromes: results from PROVE IT-TIMI 22.
Ray KK; Cannon CP; Cairns R; Morrow DA; Ridker PM; Braunwald E
Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):424-30. PubMed ID: 19122170
[TBL] [Abstract][Full Text] [Related]
14. Baseline levels of serum high sensitivity C reactive protein and lipids in predicting the residual risk of cardiovascular events in Chinese population with stable coronary artery disease: a prospective cohort study.
Dai W; Zhang Z; Zhao S
Lipids Health Dis; 2018 Dec; 17(1):273. PubMed ID: 30509306
[TBL] [Abstract][Full Text] [Related]
15. Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)--can C-reactive protein be used to target statin therapy in primary prevention?
Mora S; Ridker PM
Am J Cardiol; 2006 Jan; 97(2A):33A-41A. PubMed ID: 16442935
[TBL] [Abstract][Full Text] [Related]
16. The prevalence and predictors of elevated C-reactive protein after a coronary heart disease event.
Munkhaugen J; Otterstad JE; Dammen T; Gjertsen E; Moum T; Husebye E; Gullestad L
Eur J Prev Cardiol; 2018 Jun; 25(9):923-931. PubMed ID: 29635941
[TBL] [Abstract][Full Text] [Related]
17. C-reactive protein predicts future cardiovascular events in patients with carotid stenosis.
Schlager O; Exner M; Mlekusch W; Sabeti S; Amighi J; Dick P; Wagner O; Koppensteiner R; Minar E; Schillinger M
Stroke; 2007 Apr; 38(4):1263-8. PubMed ID: 17322087
[TBL] [Abstract][Full Text] [Related]
18. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women.
Ridker PM; Hennekens CH; Buring JE; Rifai N
N Engl J Med; 2000 Mar; 342(12):836-43. PubMed ID: 10733371
[TBL] [Abstract][Full Text] [Related]
19. Comparative effects of 10-mg versus 80-mg Atorvastatin on high-sensitivity C-reactive protein in patients with stable coronary artery disease: results of the CAP (Comparative Atorvastatin Pleiotropic effects) study.
Bonnet J; McPherson R; Tedgui A; Simoneau D; Nozza A; Martineau P; Davignon J;
Clin Ther; 2008 Dec; 30(12):2298-313. PubMed ID: 19167589
[TBL] [Abstract][Full Text] [Related]
20. [Predictive value of fibrinogen and high-sensitivity C-reaction protein for cardiovascular events in patients with stable coronary artery disease].
Huang W; Chen QW; Lei H; Deng W; Ke DZ
Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Aug; 34(8):718-21. PubMed ID: 17081398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
